Disclosed are 5-triposphate oligoribonucleotides, pharmaceutical compositions comprising said 5-triposphate oligoribonucleotides, and methods of using said 5-triposphate oligoribonucleotides to treat viral infections.Linvention concerne des oligoribonucléotides 5-triphosphate, des compositions pharmaceutiques comprenant lesdits oligoribonucléotides 5-triphosphate, et des procédés dutilisation desdits oligoribonucléotides 5-triphosphate pour traiter des infections virales.